1 2003). crestor muscle weakness statin wars.". Lancet 362 (9393): 1341. PMID 14585629.McKillop T (November 1 2003). "The statin wars.". Lancet 362 (9393): 1341. PMID 14585629.McKillop T (November 1 2003). "The statin crestor muscle weakness why AstraZeneca must retreat.". Lancet 362 (9394): 1498. PMID 14602449.^ Food and Drug.

• Lovastatin • crestor muscle weakness • Pitavastatin • Pravastatin • Rosuvastatin • SimvastatinFibrates Clofibrate‡ • Bezafibrate • Aluminium clofibrate • Gemfibrozil • Fenofibrate • Simfibrate • Ronifibrate • Ciprofibrate • Etofibrate • ClofibrideBile acid sequestrants Colestyramine • Colestipol • crestor muscle weakness • ColesevelamNiacin crestor muscle weakness derivatives Niceritrol • Niacin crestor muscle weakness Nicofuranose• Aluminium nicotinate• Nicotinyl alcohol • AcipimoxCETP inhibitors Anacetrapib† • Torcetrapib§Combinations crestor muscle weakness • Niacin/simvastatin • Ezetimibe/simvastatinOther Dextrothyroxine • Probucol • Tiadenol • Benfluorex • Meglutol • Omega-3-triglycerides • Magnesium pyridoxal 5-phosphate glutamate • Policosanol • Ezetimibe†Undergoing crestor muscle weakness trials. ‡Withdrawn from market. §Development terminated due to safety concerns.Retrieved from "http://en.wikipedia.org/wiki/Rosuvastatin"Categories: Statins | AstraZenecaHidden categories: All articles with unsourced statements since January 2008 RosuvastatinFrom.

introduction in Europe, Richard Horton, the editor of the medical journal The crestor muscle weakness criticised the way Crestor had been on the market.